|
Volumn 7, Issue 9, 2004, Pages 819-821
|
GPCR allosterism and accessory proteins: New insights into drug discovery
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID;
[4 [4 (1 BUTYL) 3 (CYCLOHEXYLHYDROXYMETHYL) 2,5 DIOXO 1,4,9 TRIAZASPIRO[5.5]UNDEC 9 YLMETHYL]PHENOXY]BENZOIC ACID;
AF 21013;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
BETA ADRENERGIC RECEPTOR;
BETA ARRESTIN;
CALCITONIN RECEPTOR;
CGP 13501;
CGP 7930;
CHOLINERGIC RECEPTOR;
CINACALCET;
EGLUMETAD;
G PROTEIN COUPLED RECEPTOR;
GLUTAMATE RECEPTOR;
GR 189011X;
GS 39783;
LY 379628;
LY 487379;
MARAVIROC;
MUSCARINIC RECEPTOR;
N (2,3 DIPHENYL 1,2,4 THIADIAZOL 5(2H) YLIDENE)METHANAMINE;
NEW DRUG;
PERIPLAKIN;
UNCLASSIFIED DRUG;
AGONIST;
ALLOSTERISM;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG APPROVAL;
DRUG RECEPTOR BINDING;
DRUG RESEARCH;
DRUG STRUCTURE;
DRUG TARGETING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERCALCEMIA;
PROTEIN PROTEIN INTERACTION;
SECONDARY HYPERPARATHYROIDISM;
ALLOSTERIC REGULATION;
ALLOSTERIC SITE;
ANIMALS;
BIOLOGICAL PRODUCTS;
DRUG DESIGN;
HUMANS;
INTERNATIONALITY;
MODELS, MOLECULAR;
PROTEIN BINDING;
PROTEIN CONFORMATION;
RECEPTORS, CELL SURFACE;
RECEPTORS, G-PROTEIN-COUPLED;
SCOTLAND;
|
EID: 5044222934
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|